Jazz Pharmaceuticals to Acquire Actio Biosciences, Expanding Rare Epilepsy Portfolio, Valued at $1.32 Billion
On Aug. 10, 2026, Jazz Pharmaceuticals and Actio Biosciences announced the companies have entered into a definitive agreement…
On Aug. 10, 2026, Jazz Pharmaceuticals and Actio Biosciences announced the companies have entered into a definitive agreement…
On Aug. 10, 2026, Bristol Myers Squibb (BMS) announced the selection of Houston, Texas, as the site for…
On Aug. 10, 2026, scientists at St. Jude Children’s Research Hospital announce they have created a single-cell atlas…
On Aug. 10, 2026, Chinese researchers have created an open-source AI system capable of bridging the gap between…
On Aug. 10, 2026, the Institute for Health Metrics and Evaluation (IHME), an independent research organization at the…
On Aug. 10, 2026, Labcorp announced that the U.S. Food and Drug Administration (FDA) had approved Labcorp’s PGDx elio®…
On Aug. 7, 2026, The Centers for Disease Control and Prevention (CDC) confirmed 94 new measles infections—most of…
On Aug. 6, 2026, The Africa Centres for Disease Control and Prevention (Africa CDC) and the World Health…
On Aug. 6, 2026, the Food and Drug Administration announced it has approved a new kind of flu…
On Aug. 6, 2026, scientists at Rockefeller University’s Jarvis lab announced that they have assembled the first fully…
On Aug. 6, 2026, Roche announced the availability of two new flexible and cost-effective research PCR testing options…
On Aug. 5, 2026, researchers at Dell Medical School at The University of Texas at Austin in collaboration…
On Aug. 5, 2026, a team of Stanford University scientists announced using an AI model of their own…
On Aug. 5, 2026, the National Science Foundation (NSF) has awarded a $20 million grant to a collaboration…
On Aug. 5, 2026, Takeda announced that the U.S. Food and Drug Administration (FDA) had approved ORZEYFUL™ (oveporexton),…
On Aug. 5, 2026, an international team led by researchers at MIT’s Koch Institute, the Broad Institute, the…
On Aug. 3, 2026, Michigan, state health officials announced that two people have died in the cyclospora outbreak,…
On Aug. 3, 2026, UCLA researchers announced they have grown brain cells from dozens of genetically distinct donors…
On Jul. 31, 2026, Novartis announced the US Food and Drug Administration (FDA) approved Pluvicto® (lutetium Lu 177…
On Jul. 30, 2026, a study led by Cedars-Sinai Health Sciences University investigators found that women who test…
On Jul. 30, 2026, researchers at the University of Virginia’s (UVA) Department of Radiology and Medical Imaging have…
On Jul. 30, 2026, researchers and clinicians from the University of Liverpool and the Clatterbridge Cancer Centre (CCC)…
On Jul. 30, 2026, Resilience, a technology-forward contract development and manufacturing organization dedicated to broadening access to complex…
On Jul. 29, 2026, Octapharma, the largest privately owned and independent plasma fractionator in the world, has formally announced plans to establish its first-ever United States-based manufacturing and…
On Jul. 29, 2026, the U.S. Food and Drug Administration (FDA) announced it has licensed Ezplaz Freeze Dried…
On Jul. 29, 2026, the U.S. Department of Agriculture (USDA) announced it will spend $25 million on a…
On Jul. 28, 2026, The U.S. Food and Drug Administration (FDA) announced it had approved SimpleScreen™ CRC, a…
On Jul. 28, 2026, a research team from the Institute for Quantum Computing (IQC) at the University of…
On Jul. 27, 2026, Michigan health officials reported 9,253 cases of cyclosporiasis, an increase of 1,077 cases since…
On Jul. 27, 2026, argenx, a global immunology innovation company, and Dallas-based Forte Biosciences announced that the companies…